<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Jeffres Featured on Epidemiology Podcast

Is intravenous to oral conversion worth the effort?

minute read

Written by SOP Communications on October 12, 2022

In a Society of Healthcare Epidemiology of American (SHEA) podcast, Dr. Megan Jeffres, PharmD, BCIDP, discusses why intravenous (IV) to oral (PO) conversion has immense potential to benefit patients by preventing unnecessary intravenous therapy associated with risks such as prolonged length of stay, line-associated infections, and excess cost and inconvenience.

Listen to the podcast



Topics: Pharmacy, Podcast